http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200074691-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f140c24f626576edd1510c41b0adab42 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1761 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
filingDate | 2018-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aa8366277d9464eb9cb1195c2ce6b29 |
publicationDate | 2020-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20200074691-A |
titleOfInvention | Anticancer composition comprising stomach cancer cell line-derived autocrine motility factor as effective component |
abstract | The present invention relates to an anti-cancer composition containing AMF derived from a gastric cancer cell line as an active ingredient, and more specifically, AMF derived from a gastric cancer cell line of the present invention suppresses the proliferation of brain cancer or colorectal cancer and is excellent in causing apoptosis. , The composition of the present invention containing AMF derived from a gastric cancer cell line as an active ingredient may be used as an anti-cancer agent. |
priorityDate | 2018-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1018.